Round and flat zygomatic implants: effectiveness after a 1-year follow-up non-interventional study
International Journal of Implant Dentistry volume 8, Article number: 13 (2022)
There are few zygomatic implants (ZI) designs available. The objective of this non-interventional study was to report the effectiveness of two new site-specific ZI, selected and placed following the zygoma anatomy-guided approach (ZAGA).
Materials and methods
Consecutive patients presenting indications for rehabilitation using ZI were treated according to ZAGA Concept recommendations. Implants were immediately loaded following the manufacturer’s instructions. Success criteria regarding prosthetic offset, rhino-sinus status, soft tissue condition, and implant stability were additionally used as outcome parameters.
Twenty patients were followed for a period of 12 to 28 months (average 18.8 months). Ten received 2 ZI plus regular anterior implants; One received 3 ZI plus regular implants and nine received 4 ZI. In total, 59 ZI were placed, 34 (58%) Straumann ZAGA-Flat design, and 25 (42%) ZAGA-Round. Forty-nine percent of the sites were classified as ZAGA-4 type and 27% as ZAGA-2. Four patients (20%) presented discontinuities of the sinus–nose floor before surgery and 15 patients (75%) presented previous sinus opacities. All implants bar one reached more than 45 N.cm of insertion torque. No surgical complications were observed. After 1 year, the modified Lund–Mackay score was negative in 17 patients. Seventeen sites in 11 patients exhibited decreased opacity when pre-surgical imaging was compared to 1-year post-surgical CBCT. All implants and prostheses remained stable and in function.
The study concluded 100% implant/prosthesis survival rates and low complication levels. Within the limitations of the sample and observation period, results suggest that even in cases of extremely resorbed maxillae (as per cases in this study), ZAGA-Flat and ZAGA-Round ZI are viable treatment options when restoring atrophic maxillae following the ZAGA protocol.
For decades, zygomatic implants have been employed to rehabilitate atrophic maxillae and to reconstruct congenital and acquired maxillary defects . Currently, multiple zygomatic implants are successfully implemented to manage patients with extremely resorbed maxillae [2,3,4]. Recently, Davó et al. conducted the first randomized controlled trial comparing zygomatic implant treatment to conventional implant treatment in augmented maxillae . Results showed that immediately loaded zygomatic implants had fewer prosthetic complications, higher implant survival rates, shorter treatment periods, and better patient acceptance.
Previously described systems for the installation of zygomatic implants, such as the Original Procedure [1, 6, 7], the Slot Technique , or the Extra-Sinus Approach [9,10,11,12,13] support a unique surgical process to be applied for all patients. However, different morphologies of the edentulous maxilla have been identified, both between individuals and intra-individuals . Therefore, the use of the same osteotomy type in all situations (i.e., “window” plus intra-sinus entrance, “slot” plus crestal osteotomy, or “extra-maxillary” pathway) will frequently generate complications. These include bulky prosthetic constructions, impaired hygiene, sinus complications, and or soft tissue dehiscence.
The Zygomatic Anatomy-Guided Approach (ZAGA) [14, 15] was described as a guideline to assist in the selection of the correct technique for each implant pathway depending on the anatomy of the patient to prevent complications. The concept aims to provide the surgeon with a decision-making protocol for both the implant path and surgical technique when planning. Thus, the ZAGA Concept is a “patient-specific therapy” as it adapts the procedure to the anatomy of each patient (Fig. 1). The determination of the implant path depends on prosthetic, bio-mechanic, and anatomic criteria. While using the ZAGA Concept to plan and execute, the implant path may be intra-sinus, extra-sinus, or reach multiple intermediary positions using the maxillary wall as an additional source of anchorage. Usually, no initial window or slot is opened at the lateral wall of the maxillary sinus. This approach has been described and used in different studies and publications [16,17,18,19].
The ORIS criteria of success for ZI  have been used to holistically follow up on each patient. Using the ORIS criteria, comparative study results, between the original technique and the ZAGA Concept, consistently show less traumatic osteotomy; better implant stability, and bone-to-implant contact; together with improved bone sealing around the implant neck. Additionally, the rate of late sinus complication dramatically decreases, and greater anatomic rehabilitation is achieved .
Because the zygomatic implant path involves the atrophic alveolar bone, the maxillary wall, and the zygomatic bone, it presents greater irregularities than the implant path in a regular implant indication. While there are numerous regular implant designs that can be used on the residual alveolar bone, the selection of the implant design, i.e., length, diameter, shape, etc., should be determined in accordance with residual bone quality or quantity. Despite many patients presenting with anatomical differences in the complex formed by the atrophic alveolar remanent, the anterior maxillary wall, and the zygomatic bone, very few zygomatic implants designs are available .
Randomized controlled trials provide strong insights into the safety and effectiveness of a product. However, these studies may not be realistically performed in the case of patients presenting severely atrophic maxillae. Due to the high variability among patients, the statistical power required to design a randomized controlled trial with such variability makes it extremely complex and lengthy to implement. Also, inclusion and exclusion criteria may not precisely replicate the condition of a dental office and can result in varying success rates [23, 24]. For these reasons, it has been argued that the results of clinical studies may lack external validity and might not be representative of actual outcomes seen in a general population, thus indicating the need for complementary observational studies . Although there is more freedom in treatment decisions with an observational study, the systematic documentation of the use of each device, and the resulting clinical outcomes provide an overall assessment of how the device performs in clinical practice over time .
The objective of this non-interventional study is to report and evaluate the safety and performance of two “site-specific” zygomatic implant designs in a series of patients in different centers following the ZAGA protocol. Observations were carried out over a minimum of one-year post-loading, using the ORIS criteria.
Material and methods
This is a prospective non-interventional study. The study subjects were patients who presented with indications for zygomatic implants and agreed to participate in the study. After an evaluation of the patient’s general health status, and a comprehensive assessment of the maxillary defect in relation to the final prosthesis, the criteria used for the indication of ZI placement were mainly radiological. Therefore, guidelines followed the checklist for radiological evaluation as published by Aparicio et al. . The number of zygomatic implants was decided by the residual anatomy of the maxilla. According to Bedrossian et al. , when it was possible to place regular implants (longer than 10 mm) in areas between canine abutments, but was not possible to treat posterior molar and premolar areas without using bone grafts, then placement of two posterior zygomatic implants, plus regular implants in the anterior area, was indicated. In cases where alveolar bone height was less than 4 mm in the molar and premolar areas of the maxilla or less than 10 mm in the anterior area, the placement of four zygomatic implants was indicated. This same indication was used when the alveolar architecture of the maxillary anterior areas was considered unfavorable for placement of regular implants without additional augmentation or bone regeneration procedures. Patients with sufficient maxillary bone that could be rehabilitated using conventional straight or tilted implants were excluded . Subjects were considered smokers when exceeding 10 cigarettes per day. Since this was a non-interventional study, no other specific inclusion/exclusion criteria existed. All the implants were installed by the same surgeon (CA) with extensive experience in zygomatic implant surgery. Five different clinicians with high experience in full arch rehabilitation and implant maintenance participated in the restorative treatment of the patients.
According to the manufacturer’s surgical and prosthetic procedures, the Straumann® Zygomatic Implant System includes two different designs: the Straumann® ZAGA™ Round with circular section and the Straumann® ZAGA™ Flat with a circular segment section on its body and coronal parts. Both incorporate a head angle correction of 55°. Apical regions are roughened, threaded and tapered for both implant designs. Both have smooth machined surfaces at the body and coronal regions. This implant system uses a fixture mount having the same diameter as the coronal part of the implant head (4.3 mm). Both implants are indicated for immediate loading when good primary stability is achieved, and with appropriate occlusal loading (Fig. 2).
All patients underwent an oral and radiological examination including a maxillary CBCT before zygomatic implant placement. The scan was used for digital planning using DTX Studio Implant software (Nobel Biocare AG). Virtual implant osteotomy trajectories were established using the zygoma anatomy-guided approach (ZAGA). Indeed, the ZAGA Concept uses a prosthetically driven zygomatic implant trajectory adapted to each patient’s anatomy. Therefore, implant trajectories varied from externalized to intra-sinus [14, 16]. The ZAGA Concept includes a minimally invasive osteotomy, the goals of which have been described by Aparicio et al. [6, 16,17,18] and are shown in Table 1.
The subjects' treatment generally included diagnostics, surgery, immediate prosthesis delivery within 24 h, and follow-up after implant loading. The follow-up included 2 week and 4-month visits after immediate loading of the screw-retained provisional prostheses, along with necessary visits for final prostheses delivery. Afterward, a follow-up control visit was scheduled every 6 months. The first annual control included a CBCT. Medical and dental history was recorded at baseline, and complications were recorded throughout the entire study period. All aspects of Implant planning and placement were recorded. These included the type, size, and location of each implant, insertion torque, abutment type, and length.
The volume and architecture of the alveolar/basal process and the curvature of the anterior maxillary wall were crucial factors for establishing the coronal implant position. When the bone architecture at the nasal/sinus floor level was considered sufficient to house the implant neck (that is, ≥ 4 mm high and 6 mm wide) in an adequate alveolar architecture, all attempts were made to place the implant using a tunnel-shape osteotomy (Figs. 2, 3). The term “tunnel osteotomy” is used because the alveolar osseous entry point has a floor, lateral walls, and a more or less complete roof. When a tunnel osteotomy was chosen, the sinus membrane was perforated at the time of completion of the antrostomy. The objective was to achieve osseointegration at the neck level also to seal the sinus entrance in the long term using: (1) a stable zygomatic implant with (2) a suitable threaded neck section (3) bordered by enough bone at the coronal entry, (4) stabilized by adequate apical zygomatic anchorage; and (5) connected to a rigid prosthesis that provides adequate masticatory load distribution. The tunnel osteotomy was also employed in ZAGA Type 3 cases when the alveolar bone adopts a triangular, buccally inclined, profile and the maxillary anterior wall was concave (Figs. 2, 4). The tunnel type of osteotomy is typically used on ZAGA types 0, 1, and 3 and has a circular section entry point that will be sealed by a round implant. Thus, a Straumann® ZAGA™ Round zygomatic implant was chosen.
When inadequate residual bone architecture at the crestal level (< 4 mm of thickness) was measured, the coronal osteotomy was buccally shifted to prevent future sinus or nasal–oral communication/fistula (Figs. 2, 5a–d). Implant beds were designed to be carved as much as possible into both the buccal alveolar and maxillary wall bone with the limits of sinus lining integrity. This osteotomy type is known as a “channel osteotomy and is noted when lateral walls and floor are present but no roof” Because the Straumann® ZAGA™ Flat design had a circular segment section, it was chosen to fit the channel and present its flat surface against the soft tissue. As such, it was expected to reduce vascular soft tissue compression.
After implant surgery, an immediate screw-retained provisional prosthesis was placed in all patients. The design of the immediate prostheses was decided by each center, in accordance with the desired treatment plan for the subject. A non-smoking period of at least 2 weeks and a soft diet for 3 months were strongly recommended. Following a period of at least 4–6 months, a more elaborated screw-retained prosthesis was delivered (Fig. 5e).
In addition to recording possible complications during surgery and other complications common with regular implants such as a lack of integration or infections, the outcome—that is, the combination of the ZAGA protocols together with the new Straumann® Zygomatic Implant System—was evaluated using the ORIS criteria for a systematic report of ZI-related rehabilitation . Four specific and objective criteria were used to evaluate the success of the rehabilitation:
Offset-evaluation of prosthetic success based on final positioning of the zygomatic implant with respect to the center of the alveolar crest: Using appropriate coronal cuts, distances (d) from the palate half-way point to the crest midpoint (P–C), and distances from the palate half-way point to each implant head center (P–I) were measured. Distance P–C minus distance P–I indicates the distance from the middle of the crest to the epicenter of the implant head. A positive value indicates a palatal position of the implant, whereas a negative value would indicate a buccal emergence of the implant  (Fig. 6).
Rhino-sinus evaluation: In 2014, Aparicio et al. suggested a system to report rhinosinusitis diagnosis in patients with zygomatic implants . The system was revisited by Aparicio et al. in 2020 . Data were reported in the same way as ear, nose, and throat (ENT) literature for conventional patients with some particularities. Essentially, sinus health after ZI installation was clinically and radiographically assessed following the Lanza–Kennedy (L-K) task force for rhinosinusitis clinical diagnosis . The presence of clinical symptoms was used to grade the rhino-sinus situation of each patient over time. Patients received a Cone Beam Computed Tomography (CBCT) scan before surgery and again at one-year post-loading. Maxillary sinuses were examined by comparing both CBCT scans according to a modified Lund–Mackay (M L-M) score [20, 28] incorporated in the ORIS criteria (Fig. 7).
Soft tissue infection/inflammation evaluation: Any signs of infection or dehiscence were evaluated using a grading scale based on referenced photographs. In this regard, all subjects had photographic documentation of implant sites throughout the course of the study. The stability or progression of soft tissue recession was assessed together with the presence, or absence of, visual soft tissue inflammation or exudative signs (Fig. 4d).
Stability evaluation: When implant stability was checked, prostheses were unscrewed. Each implant was tested individually, accepting some mobility as a criteria for success. Dis-osseointegration, signs of rotation or apical pain were considered signs of failure.
Based on these criteria, one of five possible conditions were assigned (Table 2). Two blinded, independent researchers (B Al-N and WP) from different centers analyzed and classified the radiological and clinical results according to the ORIS criteria . Analysis was based on the comparison of pre-operative and post-operative CBCT images and clinical pictures of the implant positioning, mucosal status, and occlusal prosthesis’s view.
Twenty consecutive patients with indications for zygoma-related rehabilitation were treated. The first annual check-up included a CBCT. However, not all patients attended the annual check-up on time, as some of them did it later. Thus, the observation time calculated for this study is the time between the surgery and the last CBCT, regardless of the fact that other subsequent controls were eventually performed, which for ethical reasons did not include new CBCTs (Table 3). The first patient underwent zygomatic surgery in June 2019, and the last surgery was performed in October 2020. Once treated, patients were followed for a period between 12 and 28 months (mean follow-up 18,8 months) (Table 3).
Ten patients received 2 zygomatic implants plus regular anterior implants; 9 received 4 zygomatic implants and 1 patient received 3 zygomatic implants plus 2 regular implants on the anterior maxilla. In total, 59 zygomatic implants were placed, 36 Straumann® ZAGA-Flat and 23 Straumann® ZAGA-Round designs. Implant distribution by type and position is detailed in Tables 3, 4 and 5. Seven (35%) of the subjects were considered smokers. Four patients (20%) presented previous discontinuities of the sinus–nose floor (Table 3). Fifteen patients (26 sites) presented previous maxillary sinus opacities. Out of them, 1 patient (P-6) presented 2 sites on the same maxillary sinus that severely affected ostium patency.
All implants reached more than 45 N.cm of insertion torque except four implants in the same patient. All implants were connected with screw-retained abutments suitable for the construction of screw-retained prostheses. All patients received an immediate screw-retained prosthesis within 4 to 24 h. After completion of follow-up, 100% survival rates of both the implant and prosthesis were noted in all patients.
Prostheses offset (the “O” criterion)
The center of the implant head was consistently located at the residual alveolar crest when the flat design was used; or at most, 4 mm palatal when the round design was used (Fig. 8).
The evaluation of implant head emergence led to a “success level I” in all patients.
Rhino-sinus condition (the “R” criterion)
17 patients showed either transparency or non-increased maxillary sinus opacity when comparing pre-surgical with 1-year post-surgical CBCT scans. Indeed, 17 patients had (−) Modified Lund–Mackay.
Three sites in three different patients displayed a light increased opacity that did not affect ostium patency and had no clinical significance: three patients had ( +) Modified Lund–Mackay). Success level II”.
One patient (P18) revealed clinical and radiological signs of acute rhinosinusitis in the right maxillary sinus one week after surgery. This followed the placement of a ZAGA-Flat implant using a channel-type osteotomy. The symptoms disappeared completely after standard medical treatment. One year later, a new CBCT showed total transparency with no signs of mucosal inflammation. The left side, where an anterior ZAGA-Round and a posterior flat ZI were placed, remained asymptomatic and without signs of inflammation during the entire process (Fig. 9a, b). As a result, the patient was classified as (−) Modified Lund–Mackay.
17 sites in 11 different patients exhibited decreased or no opacity when comparing pre-surgical with 1-year post-surgical CBCT scans (Fig. 10a, b).
The Lanza–Kennedy (L-K) for rhinosinusitis clinical diagnosis was found to be negative at the one-year control in all patients.
The evaluation of the rhino-sinus condition led to a “success level I” in 17 patients to a success level “II” in 3 patients.
Soft tissue stability/infection (the “I” criterion)
Four implants showed non-inflammatory soft tissue alterations. In one patient, two flat design implants presented non-inflamed soft tissue recession together with inadequate prosthesis design (Fig. 11a, b). One round design implant showed recession with no inflammation despite signs of plaque accumulation, and in a heavy smoker, one round implant design showed a mucosal fenestration with no inflammation at the 18-month control.
The evaluation of soft tissue stability led to a “success level I” in 17 patients, to a success level “II” in 2 patients, and a “success level III” in one patient.
Implant stability (the “S” criterion)
Fifty-eight implants were considered stable. One implant placed in an extremely atrophic maxilla and zygoma showed slight intrusion movement but the patient felt no pain or rotational motion (Fig. 12). 29 months after surgery, this implant was still functioning.
The evaluation of implant stability led to a “success level “I” in 19 patients, and a “success level III” in one patient.
This prospective non-interventional study evaluated clinical outcomes of treatment with new zygomatic implants designs according to the ZAGA Concept. Indeed, all zygomatic implants in this study were placed following the ZAGA Concept and, using site-specific zygomatic implants.
As there were no intraoperative complications, in the analysis of the behavior of the new implants more emphasis on late complications specific to the zygomatic implants has been given. The few late complications that did appear could not be related to the type of ZAGA implant used. The choice of either one implant design or another is made in relation to a specific anatomical situation. Consequently, the occurrence of a complication related to the implant design also occurs in different, and not comparable situations.
ORIS criteria allowed clinicians to follow up with their patients using standardized success criteria and to objectively evaluate the prosthetic aspect, the maxillary sinus status, the peri-implant soft tissue condition, and also, zygomatic implant stability .
Results revealed that the healing process was uneventful, with none of the implants showing relevant clinical problems including fistulas The ZI survival rate of 100% found in this study is consistent with other studies using a similar clinical follow-up. A recent meta-analysis reports a survival rate of 98.35% for the follow-up of 6 to 12 months  while a systematic review on immediate loading ZI reports a survival rate range of 96–100% .
In this study, the use of the Lanza–Kennedy clinical task force and Lund–Mackay radiological score should be noticed because they provide a standardized system to classify sinus status. Fifteen patients (26 sites) presented previous maxillary sinus opacities, 1 patient presented preoperative opacity in 2 sites severely affecting ostium patency, and four patients (20%) presented previous discontinuities of the sinus–nose floor. However, just 1 patient experienced immediate postoperative sinusitis, and it was clinically and radiologically solved with medical treatment. Seventeen patients showed either transparency or non-increased maxillary sinus opacity when comparing pre-surgical conditions with 1-year post-surgical CBCT. Three sites in 3 different patients displayed a light increased opacity with no clinical significance. The authors have no explanation for the fact that 17 sites in 11 different patients exhibited decreased or no opacity when comparing pre-surgical with, at least, 1-year post-surgical CBCT scans (Fig. 10a, b). This is probably related to the anatomically guided way of placing zygomatic implants together with the use of site-specific ZAGA implant designs. However, this theory should be further investigated in a longer follow-up setting.
The results of the present study seem to be in contradiction with the results obtained by Zhao's group whereby after the insertion of 84 zygomatic implants, a thickening of the membrane was observed over time. This is in addition to a noticeable decrease in the permeability of the ostium . Yet, according to Zhao and coworkers, the ZAGA protocol was followed where they describe the use of a slot in the maxilla prior to implant placement. Additionally, they do not give clear data for the choice of the location of the zygomatic implant critical zone. These are deviations in the ZAGA surgical protocol and they could explain the differences in results between the two studies in terms of post-surgical thickening of the sinus lining or decreased patency of the ostium.
Routine soft tissue assessment is necessary to understand whether or not the rehabilitation is a success. In this regard, it is important to describe not only the presence of a recession but also the stability of such a recession over time. The presence of associated mucosal infection and related esthetic problems are also key parameters to be analyzed. All patients involved in the study were examined and assessed on the quality of the soft tissues surrounding the zygomatic implants according to ORIS criteria in a standardized manner. Although being a common clinical complication in the long term, soft tissue recession is sporadically reported in peer-reviewed publications [31, 32].
In a recent multicenter study following the same clinical approach, the vast majority of implants were placed extra-sinus or in the wall of the maxilla (ZAGA II–IV), and just a minority were placed in an intra-sinus position . This seems to be similar to the situation found in this study. This reflects the anatomical situation of the patients presenting maxillary bone atrophy. It also demonstrates that the placement of zygomatic implants by means of the ZAGA approach may avoid the sinus space in most cases.
All implants included in this study were loaded immediately, i.e., within 48 h of placement. Application of the immediate loading protocol was enabled by the general achievement of high primary stability, as measured by the final insertion torque. The authors attribute this to both the tapered design of the zygomatic implants and the minimally invasive under-preparation of the implant sites.
Fifty percent of the sites were classified as ZAGA type 4, and 27 of the sites were classified as ZAGA type 2. In addition, 20% of the patients had discontinuities in the floor of the sinus or nose or both. This demonstrates the fact that most of the patients treated in this study had extreme maxillary atrophy. Patients with severe or extremely severe bone resorption were treated using quadruple zygoma installation. In those patients, the use of narrow tapered implants and the ZAGA concept enabled immediate loading protocols without prior regenerative approaches. Consequently, the patients were provided with a fixed provisional prosthesis, thereby shortening time-to-teeth, especially when compared to alternative bone grafting procedures. Immediate implant loading, as performed in this study, is a valuable treatment option because it offers the patient an immediate restoration of function, esthetics, and social confidence .
Subjects included in controlled clinical studies are selected based on strict inclusion and exclusion criteria and may not necessarily reflect the normal patient population found in a dental practice . In this study, no exclusion criteria regarding tobacco consumption or sinus status, other than acute infection have been used. Indeed 75% of all treated patients presented partial or even total sinus occupancy, 25% were heavy smokers and 20% of them had bony defects/discontinuities at the sinus or nasal level. For these reasons, it has been argued that the results of clinical studies may not be representative of actual outcomes seen in a general population, thus indicating the need for additional observational studies . Although there is more freedom in treatment decisions with an observational study, the systematic documentation of the device’s usage and clinical outcome provides an overall assessment of the device’s effectiveness ].
Within the confines of patient limitation, a non-interventional study design, and a follow-up period of 12 to 28 months (average 18,8 months), the rehabilitation of the atrophic maxilla by means of new ZI designs resulted in a low complication rate, even in extreme anatomical situations like the ones accepted in this study. Moreover, the 100% survival rates of both the implant and prosthesis indicate that the use of ZAGA-Flat and ZAGA-Round zygomatic implants following the ZAGA protocol offers a viable treatment option when restoring the extremely resorbed maxillae.
Availability of data and materials
The data sets generated and analyzed during the present study are available from the corresponding author on reasonable request.
Zygoma anatomy-guided approach
Cone beam computed tomography
Offset (prosthetic); Rhino-sinus (status); Infection/inflammation (soft tissues); Stability (implant)
Distance from the palate half-way point to the crest midpoint distances
Distance from the palate half-way point to implant head center
Ear, nose, throat
Lanza–Kennedy task force for rhinosinusitis clinical diagnosis
- M L-M:
Modified Lund–Mackay score
Brånemark P-I, Gröndahl K, Ohrnell L-O, Nilsson P, Petruson B, Svensson B, et al. Zygoma fixture in the management of advanced atrophy of the maxilla: technique and long-term results. Scand J Plast Reconstr Surg Hand Surg. 2004;38(2):70–85.
Duarte LR, Filho HN, Francischone CE, Peredo LG, Brånemark P-I. The establishment of a protocol for the total rehabilitation of atrophic maxillae employing four zygomatic fixtures in an immediate loading system—a 30-month clinical and radiographic follow-up. Clin Implant Dent Relat Res. 2007;9(4):186–96.
Davó R, Pons O. 5-year outcome of cross-arch prostheses supported by four immediately loaded zygomatic implants: a prospective case series. Eur J Oral Implantol. 2015;8(2):169–74.
Lan K, Wang F, Huang W, Davó R, Wu Y. Quad zygomatic implants: a systematic review and meta-analysis on survival and complications. Int J Oral Maxillofac Implants. 2021;36(1):21–9.
Davó R, Felice P, Pistilli R, Barausse C, Marti-Pages C, Ferrer-Fuertes A, et al. Immediately loaded zygomatic implants vs conventional dental implants in augmented atrophic maxillae: 1-year post-loading results from a multicentre randomized controlled trial. Eur J Oral Implantol. 2018;11(2):145–61.
Aparicio C, Manresa C, Francisco K, Ouazzani W, Claros P, Potau JM, et al. The long-term use of zygomatic implants: a 10-year clinical and radiographic report. Clin Implant Dent Relat Res. 2014;16(3):447–59.
Bedrossian E. Rehabilitation of the edentulous maxilla with the zygoma concept: a 7-year prospective study. Int J Oral Maxillofac Implants. 2010;25(6):1213–21.
Stella JP, Warner MR. Sinus slot technique for simplification and improved orientation of zygomaticus dental implants: a technical note. Int J Oral Maxillofac Implants. 2000;15(6):889–93.
Aparicio C, Ouazzani W, Garcia R, Arevalo X, Muela R, Fortes V. A prospective clinical study on titanium implants in the zygomatic arch for prosthetic rehabilitation of the atrophic edentulous maxilla with a follow-up of 6 months to 5 years. Clin Implant Dent Relat Res. 2006;8(3):114–22.
Aparicio C, Ouazzani W, Hatano N. The use of zygomatic implants for prosthetic rehabilitation of the severely resorbed maxilla. Periodontol. 2000;2008(47):162–71.
Migliorança R, Ilg JP, Serrano AS, Souza RP, Zamperlini MS. Sinus exteriorization of the zygoma fixtures: a new surgical protocol. Implant News. 2006;3:30–5.
Migliorança RM, Coppedê A, Dias Rezende RCL, de Mayo T. Restoration of the edentulous maxilla using extra sinus zygomatic implants combined with anterior conventional implants: a retrospective study. Int J Oral Maxillofac Implants. 2011;26(3):665–72.
Maló P, Nobre MdA, Lopes I. A new approach to rehabilitate the severely atrophic maxilla using extra maxillary anchored implants in immediate function: a pilot study. J Prosthet Dent. 2008;100(5):354–66.
Aparicio C. A proposed classification for zygomatic implant patient based on the zygoma anatomy guided approach (ZAGA): a cross-sectional survey. Eur J Oral Implantol. 2011;4(3):269–75.
Aparicio C. Zygomatic implants: the anatomy-guided approach. 1st ed. Quintessence Pub Co; 2012.
Aparicio C, Polido WD, Chow J, David L, Davo R, De Moraes EJ, et al. Identification of the pathway and appropriate use of four zygomatic implants in the atrophic maxilla: a cross-sectional study. Int J Oral Maxillofac Implants. 2021;36(4):807–17.
Aparicio C, Polido WD, Zarrinkelk HM. The zygoma anatomy-guided approach for placement of zygomatic implants. Atlas Oral Maxillofac Surg Clin North Am. 2021;29(2):203–31.
Aparicio C, López-Píriz R, Peñarrocha M. Preoperative evaluation and treatment planning zygomatic implant critical zone (ZICZ) location. Atlas Oral Maxillofac Surg Clin N Am. 2021;29(2):185–202.
Davó R, Bankauskas S, Laurincikas R, Koçyigit ID, Mate Sanchez de Val JE. Clinical performance of zygomatic implants-retrospective multicenter study. J Clin Med. 2020;9(2).
Aparicio C, López-Piriz R, Albrektsson T. ORIS criteria of success for the zygoma-related rehabilitation: the (revisited) zygoma success code. Int J Oral Maxillofac Implants. 2020;35(2):366–78.
Aparicio C, Manresa C, Francisco K, Aparicio A, Nunes J, Claros P, et al. Zygomatic implants placed using the zygomatic anatomy-guided approach versus the classical technique: a proposed system to report rhinosinusitis diagnosis. Clin Implant Dent Relat Res. 2014;16(5):627–42.
Chrcanovic BR, Albrektsson T, Wennerberg A. Survival and complications of zygomatic implants: an updated systematic review. J Oral Maxillofac Surg. 2016;74(10):1949–64.
Filippi A, Higginbottom FL, Lambrecht T, Levin BP, Meier JL, Rosen PS, et al. A prospective non interventional study to document implant success and survival of the Straumann Bone Level SLActive dental implant in daily dental practice. Quintessence Int. 2013;44(7):499–512.
Al-Nawas B, Domagala P, Fragola G, Freiberger P, Ortiz-Vigón A, Rousseau P, et al. A prospective noninterventional study to evaluate survival and success of reduced diameter implants made from titanium-zirconium alloy. J Oral Implantol. 2015;41(4):e118–25.
Aparicio C, López-Piriz R, Peñarrocha M. Preoperative evaluation and treatment planning. Zygomatic implant critical zone (ZICZ) location. Atlas Oral Maxillofac Surg Clin N Am. 2021;29:185–202.
Bedrossian E, Sullivan RM, Fortin Y, Malo P, Indresano T. Fixed-prosthetic Implant restoration of the edentulous maxilla: a systematic pretreatment evaluation method. J Oral Maxillofac Surg. 2008;66:112–22.
Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg. 1997;117(September):S1-7.
Lund VJ, Mackay IS. Staging in rhinosinusitis. Rhinology. 1993;31(4):183–4.
Tuminelli FJ, Walter LR, Neugarten J, Bedrossian E. Immediate loading of zygomatic implants: a systematic review of implant survival, prosthesis survival and potential complications. Eur J Oral Implantol. 2017;10(Suppl 1):79–87.
Zhao K, Lian M, Fan S, Huang W, Wang F, Wu Y. Long-term Schneiderian membrane thickness changes following zygomatic implant placement: a retrospective radiographic analysis using cone beam computed tomography. Clin Oral Implants Res. 2018;29(7):679–87. https://doi.org/10.1111/clr.13259 (Epub 2018 May 17).
Davó R. Zygomatic implants placed with a two-stage procedure: a 5-year retrospective study. Eur J Oral Implantol. 2009;2(2):115–24.
Nave PD, Queralt AV. Zygomatic implants for the rehabilitation of atrophic maxillae: a retrospective study on survival rate and biologic complications of 206 implants with a minimum follow-up of 1 year. Int J Oral Maxillofac Implants. 2020;35(6):1177–86.
The authors would like to thank Drs Chou, Associate Dean for Research at Indiana University; Michel Mallaun, Head of Clinical Operations Straumann Group and Dale King from Dental Writers for their editorial help.
Ethics approval and consent to participate
This is a prospective non-interventional study. Study subjects were consecutive patients who presented with indications for zygomatic implants. All participants signed a consent form to undergo regular zygomatic surgery and prosthetic rehabilitation. Indiana University HRPP staff determined (Protocol#:12562) the present study is not human subject research and does not require further IRB review. All procedures involving human participants were in accordance with the ethical standards of the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Consent for publication
All data published here are under the consent for publication.
Carlos Aparicio is the founder president of Zygoma ZAGA Centers and occasionally provides CE activities for Straumann Group and Versah Osseodensification Company. Waldemar Polido occasionally provides CE activities for Straumann Group and Geistlich Biomaterials. James Chow and Rubén Davó occasionally provide CE activities for the Straumann Group. Bilal Al-Nawas occasionally provide CE activities and get research grants for Straumann Group, BEGO, Camlog, Dentsply, and Geistlich Biomaterials.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Aparicio, C., Polido, W.D., Chow, J. et al. Round and flat zygomatic implants: effectiveness after a 1-year follow-up non-interventional study. Int J Implant Dent 8, 13 (2022). https://doi.org/10.1186/s40729-022-00412-8